RECURRENT GLIOBLASTOMA MULTIFORME
Clinical trials for RECURRENT GLIOBLASTOMA MULTIFORME explained in plain language.
Never miss a new study
Get alerted when new RECURRENT GLIOBLASTOMA MULTIFORME trials appear
Sign up with your email to follow new studies for RECURRENT GLIOBLASTOMA MULTIFORME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo takes on deadly brain tumors
Disease control OngoingThis early-stage study tests an experimental drug called AZD1390 combined with radiation therapy for people with glioblastoma or brain metastases. The main goal is to check safety and find the best dose. About 180 participants will receive different doses of AZD1390 alongside rad…
Matched conditions: RECURRENT GLIOBLASTOMA MULTIFORME
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Belly tissue used to bypass brain barrier in cancer fight
Disease control TerminatedThis early-stage trial tests a new surgical approach for recurrent glioblastoma, an aggressive brain cancer. After standard tumor removal, surgeons place a piece of abdominal tissue (omentum) into the brain cavity to bypass the blood-brain barrier. The study involves 10 adults an…
Matched conditions: RECURRENT GLIOBLASTOMA MULTIFORME
Phase: PHASE1 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Engineered virus takes on deadly brain cancer
Disease control OngoingThis early-stage trial tests a single dose of M032, a genetically modified herpes simplex virus that produces IL-12, in 29 patients with recurrent or progressive brain tumors (glioblastoma, anaplastic astrocytoma, or gliosarcoma). The virus is infused directly into the tumor area…
Matched conditions: RECURRENT GLIOBLASTOMA MULTIFORME
Phase: PHASE1 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC